-
Johnson & Johnson to make hospital consumables at new East Africa hub in Nairobi
Healthcare products manufacturer Johnson & Johnson has set up an East African operations hub in Nairobi. The company, in a major shift in its market strategy, will now depart from the initial business set up where it worked through distributors.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
- Tags
- public health, vaccines
-
High-Pressure Spray Delivers Vaccines Directly into Cheek
As good chefs stress, presentation matters. The same holds true for vaccinemakers, who know that how you deliver the ingredients powerfully affects potency. Now, researchers have devised a gel pill that can painlessly spray vaccine into the cheek and reach cells in the underlying tissue, potentially triggering what’s known as a mucosal immune response. This, in turn, might help thwart infections with pathogens like HIV, human papillomavirus, influenza, and gonococci that enter the body through the mouth, nose, or genitals.
- Categories
- Health Care
- Region
- North America
- Tags
- vaccines
-
A Highly Preventable Disease With a Vaccine Is Silently Killing Indian Women in Their Prime
A cancer with an effective vaccine is killing thousands of women. Last year, nearly 70,000 Indians died of cervical cancer, more than anywhere else in the world. It’s the second-most common cancer among women in the country, accounting for 23% of all cases. It’s a hidden disease, often taking 20 years to show itself.
- Categories
- Health Care
- Region
- South Asia
- Tags
- vaccines
-
New Malaria Vaccine 100% Effective, But May Be Difficult to Scale
Today, a human trial for a malaria vaccine reported up to 100% protection for ten weeks following the last dose, a potential breakthrough for a vexing disease.
- Categories
- Health Care
-
Proposed Joint Venture to Produce and Sell Cuban Vaccines to Treat Cancer Seeks Investors
A joint venture between the Roswell Park Cancer Institute in Buffalo, New York, and the Center for Molecular Immunology in Havana could open its doors to new U.S. investors as early as April.
- Categories
- Health Care, Investing
- Region
- Latin America
- Tags
- vaccines
-
This Mysterious $2 Billion Biotech Is Revealing the Secrets Behind Its New Drugs and Vaccines
In a recent morning meeting of scientific leaders at Moderna Therapeutics, conversation swerved toward the philosophical. Biochemist Melissa Moore, recently hired to head RNA research at the Boston-area biotech, had something on her mind: hype.
- Categories
- Health Care
- Tags
- vaccines
-
Zika Vaccine Could Be Delayed, Unaffordable After US Army Grants Exclusive Rights to Pharma Company
The U.S. Army’s plan to grant exclusive rights to a promising Zika vaccine to a major pharmaceutical company has raised questions about whether that threatens its future affordability and availability to people in developing countries.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
- Tags
- vaccines
-
Doctors Without Borders Objects to Sanofi Receiving an Exclusive License for a Zika Vaccine
Doctors Without Borders (MSF) on Monday objected to the US government’s granting of an exclusive patent license to Sanofi Pasteur for a developing Zika vaccine, though Sanofi fired back on Tuesday explaining the risks of developing such a vaccine.
- Categories
- Health Care
The Best of NextBillion in Your Inbox Each Week!
Subscribe to NB Notes for news, jobs & on-the-ground insights from the world of emerging markets business.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.